Follow Geoffrey A. Kerchner, MD, PhD
Follow Geoffrey A. Kerchner, MD, PhD
Make a free account and we’ll email you when they’re booked to speak, or their slides or recordings are posted.
Get an email when they’re booked to speak.
Geoffrey A. Kerchner, MD, PhD
F. Hoffmann-La Roche Ltd
Vice President and Global Head of Neurodegeneration
Neurologist and neuroscientist overseeing late-stage clinical development in Alzheimer's, Parkinson's, and Huntington's diseases at Roche; previously led clinical development teams for semorinemab and gantenerumab at Genentech/Roche.
1 talk
Speaking
2026
-
Nov 16–19
19th Clinical Trials on Alzheimer's Disease (CTAD) 2026 Upcoming